Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Contact us
^
Login
BIOMARKER:
CDKN2A overexpression
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Entrez ID:
1029
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
CDKN2A overexpression
CDKN2A overexpression
Soft Tissue Sarcoma
Soft Tissue Sarcoma
olaparib + trabectedin
Sensitive: C3 – Early Trials
EACR 2021 - 3 weeks
CDKN2A overexpression
CDKN2A overexpression
Ovarian Cancer
Ovarian Cancer
palbociclib
Sensitive: D – Preclinical
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
